Atezolizumab-associated encephalitis in metastatic lung adenocarcinoma: a case report

Atezolizumab-associated encephalitis in metastatic lung adenocarcinoma: a case report

Abstract Background In recent years, immune checkpoint inhibitors have been widely used as a crucial therapy in malignant tumors. Immune checkpoint inhibitors can cause various autoimmune side effects called immune-related adverse events because they generate an exaggerated inflammatory response. En...

Full description

Bibliographic Details
Main Authors: Yoshitaka Yamaguchi, Hikaru Nagasawa, Yuji Katagiri, Manabu Wada
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Journal of Medical Case Reports
Subjects:
Atezolizumab
Encephalitis
Immune checkpoint inhibitor
Immune-related adverse event
Lung adenocarcinoma
Programmed death ligand 1 inhibitor
Online Access:http://link.springer.com/article/10.1186/s13256-020-02411-y

Internet

http://link.springer.com/article/10.1186/s13256-020-02411-y

Similar Items